FDA Inspection 1229076 — Abbott Laboratories

Abbott Laboratories — FEI 1415939

The FDA completed an inspection of Abbott Laboratories on May 29, 2024 in Abbott Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 29, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Abbott Park, IL (United States)